Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2023-06-25
DOI
10.1001/jama.2023.9696
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
- (2023) Steven E. Nissen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US
- (2023) Joshua A. Jacobs et al. JAMA Cardiology
- Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment
- (2022) Paula Byrne et al. JAMA Internal Medicine
- Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance
- (2020) Stephen J Nicholls et al. AMERICAN HEART JOURNAL
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
- (2019) Corey K. Bradley et al. Journal of the American Heart Association
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statins for primary prevention of cardiovascular disease
- (2019) Paula Byrne et al. BMJ-British Medical Journal
- Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL
- (2018) Salim S. Virani et al.
- Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL
- (2018) Salim S. Virani et al. Circulation-Cardiovascular Quality and Outcomes
- Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease
- (2018) Henock G. Yebyo et al. ANNALS OF INTERNAL MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statins for Primary Prevention
- (2017) Rita F. Redberg et al. JAMA Internal Medicine
- Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide
- (2017) Yashashwi Pokharel et al. JAMA Cardiology
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease
- (2014) Christopher M. Gamboa et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started